Castle Biosciences price target raised to $45 from $40 at BTIG
BTIG raised the firm’s price target on Castle Biosciences (CSTL) to $45 from $40 and keeps a Buy rating on the shares. The company ...
Tactile Systems downgraded to Neutral from Buy at BTIG
BTIG downgraded Tactile Systems (TCMD) to Neutral from Buy without a price target following the Q3 report. While the shares are inexpensive and ...
Tactile Systems cut to Neutral at BTIG after Q3 revenue miss
Tactile Systems (TCMD) stock was downgraded by BTIG to neutral as its Q3 revenue misses expectations. Read more here.